Autoimmune Pulmonary Alveolar Proteinosis Completed Phase 3 Trials for Molgramostim (DB12525)

Back to Autoimmune Pulmonary Alveolar Proteinosis

Also known as: Pulmonary Alveolar Proteinosis, Autoimmune / Autoimmune pulmonary alveolar proteinosis (disorder) / Alveolar proteinosis / Pulmonary Alveolar Proteinosis / Pulmonary alveolar proteinosis (disorder)

IndicationStatusPhase
DBCOND0075037 (Autoimmune Pulmonary Alveolar Proteinosis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs